Coronavirus Therapeutics Stock Comparison

Compare coronavirus therapeutics stocks. These companies are making significant advances in COVID-19 diagnostics and treatment. Get the most updated comparison by key indicators and discover each stock’s price target as well as recommendations by top Wall Street experts.
Compare up to 7 stocks

Comparison Results

Name
Price
Price Change
Price Target Upside
Market Cap
PE Ratio
Yearly Gain
Analyst Consensus
Follow
REGNRegeneron
$523.73
7.11 (1.38%)
$649.00
(23.92% Upside)
55.80B
14.70
-7.79%
7Buy
3Hold
0Sell
0
Moderate Buy
GILDGilead Sciences
$69.07
0.54 (0.79%)
$78.58
(13.77% Upside)
86.63B
285.50
-4.42%
10Buy
6Hold
0Sell
0
Moderate Buy
SRNESorrento Therapeutics
$6.65
0.03 (0.45%)
$25.00
(275.94% Upside)
1.91B
-7.10
1.85%
3Buy
0Hold
0Sell
0
Strong Buy
AMGNAmgen
$252.38
1 (0.4%)
$244.00
(-3.32% Downside)
145.01B
20.80
10.85%
8Buy
9Hold
2Sell
0
Moderate Buy
ABBVAbbVie
$116.89
0.46 (0.4%)
$126.00
(7.79% Upside)
206.45B
42.00
33.73%
11Buy
2Hold
0Sell
0
Strong Buy
GSKGlaxoSmithKline
$39.59
0.51 (1.31%)
99.60B
13.70
-1.26%
0Buy
2Hold
1Sell
0
Moderate Sell
LLYEli Lilly & Co
$195.53
-0.68 (-0.35%)
$218.80
(11.90% Upside)
187.52B
29.30
26.55%
7Buy
3Hold
0Sell
0
Moderate Buy

Performance Comparison

Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.

Coronavirus Therapeutics Stocks Latest News

Read the latest stock news and analysis from the TipRanks news team.

Recent Analysts Ratings of Coronavirus Therapeutics Stocks

Name
Analyst
Analyst Firm
Rating
Price Target
Upside / Downside
Action
Date
AMGNAmgen Inc
Buy
Assigned
ABBVAbbvie
Buy
Reiterated
REGNRegeneron Pharmaceuticals
Buy
Reiterated
SRNESorrento Therapeutics Inc
Buy
Reiterated
LLYEli Lilly & Co.
Hold
Reiterated
GILDGilead Sciences
Buy
Reiterated
GSKGlaxoSmithKline
Hold
Reiterated
REGNRegeneron Pharmaceuticals
Hold
Reiterated
REGNRegeneron Pharmaceuticals
Buy
Assigned
GILDGilead Sciences
Buy
Reiterated

Most Recent Earnings of Coronavirus Therapeutics Stocks

SYMBOL
Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
REGNRegeneron
May 06, 2021
2021 (Q1)
8.69/10.09
5.43
85.86% (+4.66)
GILDGilead Sciences
Apr 29, 2021
2021 (Q1)
2.08/1.37
1.221
12.20% (+0.15)
SRNESorrento Therapeutics
May 11, 2021
2021 (Q1)
0.42/0.01
-0.357
102.24% (+0.36)
AMGNAmgen
Apr 27, 2021
2021 (Q1)
4.05/2.83
3.072
-7.78% (-0.24)
ABBVAbbVie
Apr 30, 2021
2021 (Q1)
2.81/1.99
2.019
-1.54% (-0.03)
GSKGlaxoSmithKline
Apr 28, 2021
2021 (Q1)
0.59/0.59
0.806
-26.43% (-0.21)
LLYEli Lilly & Co
Apr 27, 2021
2021 (Q1)
2.12/1.49
1.598
-7.07% (-0.11)

Coronavirus Therapeutics Stocks - FAQ

Which Coronavirus Therapeutics stocks have a "Strong Buy" analyst rating?
These Coronavirus Therapeutics stocks currently have a "Strong Buy" analyst rating consensus:
Sorrento Therapeutics - Strong Buy, based on 3 analyst ratings, 3 Buy, 0 Hold, and 0 Sell.
AbbVie - Strong Buy, based on 13 analyst ratings, 11 Buy, 2 Hold, and 0 Sell.
Are Coronavirus Therapeutics stocks overpriced?
Regeneron's stock price is currently $523.73, and its average 12-month price target is $649.00.
Gilead Sciences's stock price is currently $69.07, and its average 12-month price target is $78.58.
Sorrento Therapeutics's stock price is currently $6.65, and its average 12-month price target is $25.00.
Amgen's stock price is currently $252.38, and its average 12-month price target is $244.00.
AbbVie's stock price is currently $116.89, and its average 12-month price target is $126.00.
GlaxoSmithKline's stock price is currently $39.59, and its average 12-month price target is N/A.
Eli Lilly & Co's stock price is currently $195.53, and its average 12-month price target is $218.80.
Which Coronavirus Therapeutics stocks pay dividends?
Regeneron does not currently pay dividends.
Gilead Sciences currently pays a dividend of $0.71 which represents an annual dividend yield of 4.14%. Gilead Sciences's next Ex-dividend date is June 14, 2021 and its next payout date is June 29, 2021.
Sorrento Therapeutics does not currently pay dividends.
Amgen does not currently pay dividends.
AbbVie does not currently pay dividends.
GlaxoSmithKline currently pays a dividend of $0.52 which represents an annual dividend yield of 5.39%. GlaxoSmithKline's next Ex-dividend date is May 20, 2021 and its next payout date is July 8, 2021.
Eli Lilly & Co does not currently pay dividends.